Senseonics Holdings, Inc. (SENS)
Market Closed
15 Oct, 08:00 PM
$
8. 23
+0.13
+1.6049%
$
386.18M Market Cap
- P/E Ratio
- Div Yield
678,060 Volume
-0.12 Eps
$ 8.1
Previous Close 
Want to track SENS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript
Senseonics Holdings, Inc. (NYSE:SENS ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Jeremy Feffer - LifeSci Advisors Tim Goodnow - President and Chief Executive Officer Rick Sullivan - Chief Financial Officer Brian Hansen - President of CGM at Ascensia Diabetes Care Conference Call Participants Brian Langan - Morgan Stanley Vernon Bernardino - H.C. Wainwright Operator Good day, everyone, and welcome to the Senseonics Third Quarter 2024 Earnings Call.
Seekingalpha | 1 year ago
Senseonics Stock Down Despite New FDA Approval for Eversense 365
SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
